Direct Care Endocrinology

02/26/2026

https://www.facebook.com/share/1DVydGAccB/?mibextid=wwXIfr

Guideline Watch: The American Diabetes Association recommends earlier and broader use of diabetes technology.

"As a generalist," writes Molly S. Brett, MD. "I’d say that the most notable change in this guideline is earlier integration of diabetes technology, including more use of automated insulin delivery devices and CGM in managing type 2 diabetes."

11/14/2025

https://telehealth.org/blog/senate-passes-cr-extending-medicare-telehealth-flexibilities-through-january-2026/?fbclid=IwZnRzaAOEe5VleHRuA2FlbQIxMQBzcnRjBmFwcF9pZAo2NjI4NTY4Mzc5AAEeF0tHr6RpSE1q5trL-dDRxk1dF6NqWBRYBrgLFdXF1SvGLBi-qiLpqGAUj-8_aem__pNVT2zFHjDiq67b28g1Qw

The Senate approved a continuing resolution on November 10, 2025, that would extend key Medicare telehealth flexibilities through January 30, 2026.

11/13/2025

Let’s spread the science, not made up benefits!!

https://www.instagram.com/reel/DQ7g16rgVhH/?igsh=M2oyMzYxZXdwdm55

11/10/2025

https://www.nytimes.com/2025/11/10/health/fda-hormone-replacement-menopause.html?nl=Breaking+News

The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient.

09/14/2025

https://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingredients

The U.S. Food and Drug Administration today established a “green list” import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from unverified foreign sources from entering the U.S. market.

09/13/2025

Great menospause and HRT discussion

For more free content like this, subscribe to our weekly newsletter: https://bit.ly/3QFJa7ATo receive exclusive access to our member-only content, subscribe ...

08/07/2025

https://www.medscape.com/viewarticle/most-glp-1-prescriptions-miss-mark-are-yours-2025a1000jts?src=mbl_msp_iphone&ref=fb&fbclid=IwQ0xDSwMBaBJleHRuA2FlbQIxMQABHgvOWc_uBZ4AWMT8nGlsT3q7jvT2DrXThWzy05X0hOB82KKGHYbdupn2sudF_aem_7gbXTRJN-lD20pJb7zBCkQ

Great review of GLP1s use and the reasons they should be prescribed by physicians with experience and expertise

Physicians detail five practical measures to optimize GLP-1 therapy and prevent muscle loss in patients undergoing weight reduction.

07/18/2025

Wonderful review of menopausal hormonal replacement therapy at the highest level of expertise: FDA expert panel review

Join the FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women. We'll discuss treatments, education, and comprehensive care beyond symptom ...

03/20/2025

Hopefully the prices of GLP1 drugs for weight loss will come down, after analyses like this one reach more payors and policy makers and the pressure to lower costs will mount.

At $200,000 per quality-adjusted life-year saved, Mounjaro doesn’t meet economic criteria for coverage.

02/28/2025

NEW
Zepbound now available in vials up to 10 mg from Lily Direct Pharmacy at 500/month with subscription. Opening the door for more patients who do not have weight loss coverage through their insurance. And probably levels the prices they would pay for compounded product from "medical spas"

For eligible and commercially insured patients, help them learn more about the cost and coverage with the Zepbound® savings card. No Gov`t beneficiaries. Terms apply.